Persistence of Rabies Antibody 1-5 Years After the Post-exposure Prophylaxis With Vero Cell Antirabies Vaccine and Antibody Response to a Single Booster Dose
Clinical trial NCT01173302 · UNKNOWN
Trial details
- NCT number
- NCT01173302
- Sponsor
- Peking University People's Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-01
- Primary completion
- 2010-08-01
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.